Literature DB >> 2578661

Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein.

H M Geysen, S J Barteling, R H Meloen.   

Abstract

Antisera were raised against the chemically synthesized peptide corresponding to each epitope of three foot-and-mouth disease virus strains. Peptide synthesis was further used to determine which amino acid residues in each epitope are important for the specificity of antisera raised against the whole virus. The specificity of the antibody paratope for its epitope was shown to depend on structure as well as sequence. Anti-virus sera demonstrated a greater specificity for the homologous peptide than did the anti-peptide sera. Two of the three peptides were able to induce neutralizing antibodies against the homologous virus. The specificities of the antibodies present in the anti-peptide sera were also inferred from the reactions of each with related sets of peptides. The cross-reactions observed for the anti-peptide sera were readily explained in terms of the antibody specificities determined to be present. The findings also suggest that the diversity of antibodies raised against small peptides is limited and is determined by the immune system. A similar limited response to the native protein was observed, which may account for the high frequency with which anti-peptide sera react with the native homologous protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578661      PMCID: PMC396995          DOI: 10.1073/pnas.82.1.178

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Isolation and characterization of trypsin-resistant O1 variants of foot-and-mouth disease virus.

Authors:  S J Barteling; R H Meloen; F Wagenaar; A L Gielkens
Journal:  J Gen Virol       Date:  1979-05       Impact factor: 3.891

2.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.

Authors:  H M Geysen; R H Meloen; S J Barteling
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

3.  Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition.

Authors:  H L Niman; R A Houghten; L E Walker; R A Reisfeld; I A Wilson; J M Hogle; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

4.  Antibodies that react with predetermined sites on proteins.

Authors:  J G Sutcliffe; T M Shinnick; N Green; R A Lerner
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

5.  The nucleotide sequence of cDNA coding for the structural proteins of foot-and-mouth disease virus.

Authors:  J C Boothroyd; T J Harris; D J Rowlands; P A Lowe
Journal:  Gene       Date:  1982-02       Impact factor: 3.688

6.  Amino acid substitution and the antigenicity of globular proteins.

Authors:  M Reichlin
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

7.  Water, protein folding, and the genetic code.

Authors:  R V Wolfenden; P M Cullis; C C Southgate
Journal:  Science       Date:  1979-11-02       Impact factor: 47.728

8.  A study of the cross-reacting antigens on the intact foot-and-mouth disease virus and its 12S Subunits with antisera against the structural proteins.

Authors:  R H Meloen; J Briaire
Journal:  J Gen Virol       Date:  1980-11       Impact factor: 3.891

9.  New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates.

Authors:  F T Liu; M Zinnecker; T Hamaoka; D H Katz
Journal:  Biochemistry       Date:  1979-02-20       Impact factor: 3.162

10.  Nucleotide sequence and corresponding amino acid sequence of the gene for the major antigen of foot and mouth disease virus.

Authors:  C Kurz; S Forss; H Küpper; K Strohmaier; H Schaller
Journal:  Nucleic Acids Res       Date:  1981-04-24       Impact factor: 16.971

View more
  46 in total

1.  Effect of core epitope modification on the antibody recognition of a MUC2 mucin peptide.

Authors:  Katalin Uray; Ferenc Hudecz
Journal:  Mol Divers       Date:  2012-03-04       Impact factor: 2.943

2.  Immunological and structural homology between human T-cell leukemia virus type I envelope glycoprotein and a region of human interleukin-2 implicated in binding the beta receptor.

Authors:  D S Kohtz; A Altman; J D Kohtz; S Puszkin
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

3.  Analysis of immune responses in the sheep to synthetic peptides of foot-and-mouth disease virus using ovine polyclonal and monoclonal antibodies.

Authors:  J N Flynn; G D Harkiss; T Doel; R DiMarchi
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

4.  Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus.

Authors:  W P Posthumus; J A Lenstra; W M Schaaper; A P van Nieuwstadt; L Enjuanes; R H Meloen
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

5.  Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis.

Authors:  L Lozzi; M Rustici; M Corti; M G Cusi; P E Valensin; L Bracci; A Santucci; P Soldani; A Spreafico; P Neri
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 6.  Schistosome vaccines.

Authors:  D W Taylor
Journal:  Experientia       Date:  1991-02-15

7.  Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.

Authors:  W M Kast; L Roux; J Curren; H J Blom; A C Voordouw; R H Meloen; D Kolakofsky; C J Melief
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

8.  A DNA Spiegelmer to staphylococcal enterotoxin B.

Authors:  Werner G Purschke; Falko Radtke; Frank Kleinjung; Sven Klussmann
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

9.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

10.  Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.

Authors:  C Bleul; M Müller; R Frank; H Gausepohl; U Koldovsky; H N Mgaya; J Luande; M Pawlita; J ter Meulen; R Viscidi
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.